Medicine composition curing gynaecological mass diseases such as fibroids and preparation method and application thereof

Abstract

The invention discloses a medicine composition curing gynaecological mass diseases such as fibroids and a preparation method and application of the medicine composition. The medicine composition mainly comprises the following raw materials: glabrous greenbrier rhizome, lightyellow sophora roots, cortex phellodendri, zedoray rhizome, rhizoma sparganic, roots of red-rooted salvia, red peony roots, szechwan chinaberry fruits, rhizoma corydalis, rhizoma corydalis, chinese angelica, Gorgon fruits and Chinese yams, extraction and purification are carried out through a certain technique, and auxiliary materials and components which are acceptable in the pharmacy are added to prepare the medicine composition. According to the preparation method, volatile components are extracted in a supercritical mode and prepared into micro-capsules to avoid loss of the volatile components, the preservation time limit of the product is promoted, and the stimulus effect on gastrointestinal tracts is reduced. The method is extensive in medicinal herbs resources and free of toxic, strong and tabooed medicines, all the effective components contribute to synergistic effects, the effective substances are clear, the quality safety is controllable, the curative effect is definite, and the medicine composition can be accepted well and is a new effective medicine curing the gynaecological mass diseases such as the fibroids.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating gynecological mass diseases such as uterine fibroids, and also relates to a preparation method and application of the pharmaceutical composition, belonging to the fields of traditional Chinese medicine, pharmacy and drug application. Background technique [0002] Uterine fibroids, ovarian cysts, breast hyperplasia and other gynecological mass diseases are frequently-occurring diseases in modern clinical practice. Among them, uterine fibroids are called "the first tumor in gynecology" and have been listed as intractable gynecological diseases from ancient times to the present. More common in women aged 30-50, the incidence rate of women over the age of 30 is about 20%, and the incidence rate of women aged 40-50 is the highest, which can be as high as 50-77%. Ovarian cyst is a kind of ovarian tumor and one of the common gynecological diseases. Its type ranks first in the tumors of variou...

AI Technical Summary

Problems solved by technology

At this stage, the existing product Guizhi Fuling Capsules in the market has weak efficacy and is not suitable for complicated gynecological mass diseases such as uterine fibroids, ovarian cysts, and breast hyperplasia, and it is reported that there are gastrointestinal adverse reactions. It is used for ground beetle, leech, etc., which will cause great damage to the patient's constitution. It is not suitable for long-term use, which may cause incomplete treatment, and cannot deal with gynecological mass diseases such as uterine fibroids, ovarian cysts, and breast hyperplasia. The disease is lingering and prone to repeated attacks. feature

None of the above treatment methods and drugs can satisfy the existing clinical treatment, clinicians lack choices, and patients have poor acceptance

Images